Point-of-Care Pregnancy Testing

2016 ◽  
Vol 15 (4) ◽  
pp. 164-171
Author(s):  
Patrick M. Sluss
Keyword(s):  
Point Of Care ◽  
Pregnancy Testing

Implementation of a pregnancy screening protocol prior to chemotherapy for women of childbearing potential.

2019 ◽  
Vol 37 (27_suppl) ◽  
pp. 246-246
Author(s):  
Christian Eastlake ◽  
Kate Jeffers
Keyword(s):  
Nursing Staff ◽  
Point Of Care ◽  
Treatment Plan ◽  
Cancer Therapies ◽  
Childbearing Potential ◽  
Continued Education ◽  
Ambulatory Oncology ◽  
Pregnancy Testing ◽  
Screening Protocol ◽  
Improve Compliance

246 Background: Many cancer therapies currently available are teratogenic in nature. Several patients cared for within our community ambulatory oncology infusion center are women of childbearing potential (WOCP). Pregnancy testing of these women within our oncology infusion center was sporadic at best. There currently are no standardized guidelines related to pregnancy testing of these women. Methods: A retrospective chart analysis of WOCP receiving chemotherapy was done to determine baseline pregnancy screening rates. Subsequently a protocol was developed in which WOCP was defined as women under 50 years of age, without a history of hysterectomy or tubal ligation. The nurse-driven protocol allowed the infusion nursing staff to order a pregnancy screen to be done within the infusion center if testing had not already taken place within 48 hours of initiation of treatment. Following protocol implementation a retrospective chart analysis was performed to re-examine screening rates. Results: Utilizing patients with an active treatment plan within a one month time period, retrospective analysis of pregnancy screening prior to initiation of chemotherapy was performed. Baseline pregnancy screening rate was 21%. Point of care pregnancy equipment was obtained and nursing staff was educated on the protocol to include a medical delegation. Post-implementation chart analysis of WOCP initiating chemotherapy within a six-week timeframe resulted in improved pregnancy screening to 57% compliance. Continued education and clarification of the protocol was provided to the nurses in an effort to further improve compliance. Conclusions: Lack of standard guidelines regarding pregnancy screening of WOCP led to the development and implementation of a protocol for pregnancy screening for this at-risk population. Medical delegation allowed nursing to initiate the screening for these patients allowing for improvements in the safety and quality of patient care provided.

Rate of Detection of Unsuspected Pregnancies After Implementation of Mandatory Point-of-Care Urine Pregnancy Testing Prior to Hysterosalpingography

2013 ◽  
Vol 10 (7) ◽  
pp. 533-537 ◽  
Author(s):  
Keith Herr ◽  
Courtney Coursey Moreno ◽  
Corinne Fantz ◽  
Pardeep K. Mittal ◽  
William C. Small ◽  
...  
Keyword(s):  
Point Of Care ◽  
Pregnancy Testing

scholarly journals Comparison of Result Times Between Urine and Whole Blood Point-of-care Pregnancy Testing

2016 ◽  
Vol 17 (4) ◽  
pp. 449-453 ◽  
Author(s):  
Michael Gottlieb ◽  
Kristopher Wnek ◽  
Jordan Moskoff ◽  
Errick Christian ◽  
John Bailitz
Keyword(s):  
Whole Blood ◽  
Point Of Care ◽  
Pregnancy Testing

64 Comparison of Total Turnaround Times for Urine versus Whole Blood Point-of-Care Pregnancy Testing Using a Nursing Protocol

2015 ◽  
Vol 66 (4) ◽  
pp. S23
Author(s):  
M. Gottlieb ◽  
K. Wnek ◽  
E. Christian ◽  
J. Moskoff ◽  
J. Bailitz
Keyword(s):  
Whole Blood ◽  
Point Of Care ◽  
Pregnancy Testing

“Hook-like Effect” Causes False-negative Point-of-care Urine Pregnancy Testing in Emergency Patients

2013 ◽  
Vol 44 (1) ◽  
pp. 155-160 ◽  
Author(s):  
Richard T. Griffey ◽  
Caleb J. Trent ◽  
Rebecca A. Bavolek ◽  
Jacob B. Keeperman ◽  
Christopher Sampson ◽  
...  
Keyword(s):  
Point Of Care ◽  
False Negative ◽  
Emergency Patients ◽  
Negative Point ◽  
Pregnancy Testing

“Aspirin - resistance”? A few critical considerations on definition, terminology, diagnosis, clinical value, natural course of atherosclerotic disease, and therapeutic consequences

VASA ◽  
2011 ◽  
Vol 40 (6) ◽  
pp. 429-438 ◽  
Author(s):  
Berent ◽  
Sinzinger
Keyword(s):  
Platelet Function ◽  
Point Of Care ◽  
Aspirin Resistance ◽  
Point Of View ◽  
Evidence Based ◽  
Platelet Function Tests ◽  
Clinical Value ◽  
Vascular Events ◽  
Therapeutic Consequences ◽  
Function Tests

Based upon various platelet function tests and the fact that patients experience vascular events despite taking acetylsalicylic acid (ASA or aspirin), it has been suggested that patients may become resistant to the action of this pharmacological compound. However, the term “aspirin resistance” was created almost two decades ago but is still not defined. Platelet function tests are not standardized, providing conflicting information and cut-off values are arbitrarily set. Intertest comparison reveals low agreement. Even point of care tests have been introduced before appropriate validation. Inflammation may activate platelets, co-medication(s) may interfere significantly with aspirin action on platelets. Platelet function and Cox-inhibition are only some of the effects of aspirin on haemostatic regulation. One single test is not reliable to identify an altered response. Therefore, it may be more appropriate to speak about “treatment failure” to aspirin therapy than using the term “aspirin resistance”. There is no evidence based justification from either the laboratory or the clinical point of view for platelet function testing in patients taking aspirin as well as from an economic standpoint. Until evidence based data from controlled studies will be available the term “aspirin resistance” should not be further used. A more robust monitoring of factors resulting in cardiovascular events such as inflammation is recommended.

Sign in / Sign up

Export Citation Format

Share Document